Skip to main content
SpringerLink
Log in

Management of Germ Cell Tumors

  • Chapter
  • First Online:
Pathology and Biology of Human Germ Cell Tumors

Abstract

Germ cell tumors typically present in younger age populations and are known to be extremely sensitive to chemotherapy and radiation. As a result of this, remarkable progress has been achieved for offering a high degree of curative outcomes for these tumor types using a stepwise, stage-specific integration of surgery, chemotherapy, and radiation. A common theme in the treatment paradigm is to offer high cure rates without compromising on fertility in this typically young population of patients. This chapter will summarize the management of germ cell tumors using testicular germ cell tumors as the prototype example since it has been studied extensively. Principles of management of malignant ovarian germ cell tumors are currently based on treatments that have evolved from the study of testicular cancer and also offer a high rate of cure.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29. doi:10.3322/caac.21254.

    Article  PubMed  Google Scholar 

  2. Einhorn LH. Treatment of testicular cancer: a new and improved model. J Clin Oncol. 1990;8(11):1777–81.

    Article  CAS  PubMed  Google Scholar 

  3. Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med. 1997;337(4):242–53. doi:10.1056/NEJM199707243370406.

    Article  CAS  PubMed  Google Scholar 

  4. Tseng Jr A, Horning SJ, Freiha FS, Resser KJ, Hannigan Jr JF, Torti FM. Gynecomastia in testicular cancer patients. Prognostic and therapeutic implications. Cancer. 1985;56(10):2534–8.

    Article  PubMed  Google Scholar 

  5. Muller J, Skakkebaek NE, Parkinson MC. The spermatocytic seminoma: views on pathogenesis. Int J Androl. 1987;10(1):147–56.

    Article  CAS  PubMed  Google Scholar 

  6. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol. 1997;15(2):594–603.

    Google Scholar 

  7. Lange PH, McIntire KR, Waldmann TA, Hakala TR, Fraley EE. Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer. N Engl J Med. 1976;295(22):1237–40. doi:10.1056/NEJM197611252952207.

    Article  CAS  PubMed  Google Scholar 

  8. Lippert MC, Javadpour N. Lactic dehydrogenase in the monitoring and prognosis of testicular cancer. Cancer. 1981;48(10):2274–8.

    Article  CAS  PubMed  Google Scholar 

  9. Gilligan TD, Seidenfeld J, Basch EM, Einhorn LH, Fancher T, Smith DC, et al. American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors. J Clin Oncol. 2010;28(20):3388–404. doi:10.1200/JCO.2009.26.4481.

    Article  CAS  PubMed  Google Scholar 

  10. Nazeer T, Ro JY, Amato RJ, Park YW, Ordonez NG, Ayala AG. Histologically pure seminoma with elevated alpha-fetoprotein: a clinicopathologic study of ten cases. Oncol Rep. 1998;5(6):1425–9.

    CAS  PubMed  Google Scholar 

  11. Klein EA. Tumor markers in testis cancer. Urol Clin North Am. 1993;20(1):67–73.

    CAS  PubMed  Google Scholar 

  12. Weissbach L, Bussar-Maatz R, Mann K. The value of tumor markers in testicular seminomas. Results of a prospective multicenter study. Eur Urol. 1997;32(1):16–22.

    CAS  PubMed  Google Scholar 

  13. Garnick MB. Spurious rise in human chorionic gonadotropin induced by marihuana in patients with testicular cancer. N Engl J Med. 1980;303(20):1177. doi:10.1056/NEJM198011133032014.

    CAS  PubMed  Google Scholar 

  14. Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, et al. NCCN clinical practice guidelines in oncology: testicular cancer. J Natl Compr Cancer Netw. 2009;7(6):672–93.

    CAS  Google Scholar 

  15. Rabbani F, Sheinfeld J, Farivar-Mohseni H, Leon A, Rentzepis MJ, Reuter VE, et al. Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse. J Clin Oncol. 2001;19(7):2020–5.

    Article  CAS  PubMed  Google Scholar 

  16. Stephenson AJ, Bosl GJ, Bajorin DF, Stasi J, Motzer RJ, Sheinfeld J. Retroperitoneal lymph node dissection in patients with low stage testicular cancer with embryonal carcinoma predominance and/or lymphovascular invasion. J Urol. 2005;174(2):557–60. discussion 60 doi:10.1097/01.ju.0000165163.03805.37.

    Article  PubMed  Google Scholar 

  17. Oldenburg J, Alfsen GC, Waehre H, Fossa SD. Late recurrences of germ cell malignancies: a population-based experience over three decades. Br J Cancer. 2006;94(6):820–7. doi:10.1038/sj.bjc.6603014.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Geldart TR, Gale J, McKendrick J, Kirby J, Mead G. Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure. BJU Int. 2006;98(2):353–8. doi:10.1111/j.1464-410X.2006.06250.x.

    Article  PubMed  Google Scholar 

  19. Fossa SD, Kravdal O. Fertility in Norwegian testicular cancer patients. Br J Cancer. 2000;82(3):737–41. doi:10.1054/bjoc.1999.0989.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Ohl DA, Sonksen J. What are the chances of infertility and should sperm be banked? Semin Urol Oncol. 1996;14(1):36–44.

    CAS  PubMed  Google Scholar 

  21. Panidis D, Rousso D, Stergiopoulos K, Papathanasiou K, Delkos D, Papaletsos M. The effect of testicular seminoma in semen quality. Eur J Obstet Gynecol Reprod Biol. 1999;83(2):219–22.

    Article  CAS  PubMed  Google Scholar 

  22. Gordon Jr W, Siegmund K, Stanisic TH, McKnight B, Harris IT, Carroll PR, et al. A study of reproductive function in patients with seminoma treated with radiotherapy and orchidectomy: (SWOG-8711). Southwest Oncology Group. Int J Radiat Oncol Biol Phys. 1997;38(1):83–94.

    Article  PubMed  Google Scholar 

  23. Motzer RJ, Agarwal N, Beard C, Bhayani S, Bolger GB, Buyyounouski MK, et al. Testicular cancer. J Natl Compr Cancer Netw. 2012;10(4):502–35.

    CAS  Google Scholar 

  24. Mortensen MS, Lauritsen J, Gundgaard MG, Agerbaek M, Holm NV, Christensen IJ, et al. A nationwide cohort study of stage I seminoma patients followed on a surveillance program. Eur Urol. 2014;66(6):1172–8. doi:10.1016/j.eururo.2014.07.001.

    Article  PubMed  Google Scholar 

  25. Oliver RT, Mason MD, Mead GM, von der Maase H, Rustin GJ, Joffe JK, et al. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet. 2005;366(9482):293–300. doi:10.1016/S0140-6736(05)66984-X.

    Article  CAS  PubMed  Google Scholar 

  26. Williams SD, Birch R, Einhorn LH, Irwin L, Greco FA, Loehrer PJ. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med. 1987;316(23):1435–40. doi:10.1056/NEJM198706043162302.

    Article  CAS  PubMed  Google Scholar 

  27. Jules-Elysee K, White DA. Bleomycin-induced pulmonary toxicity. Clin Chest Med. 1990;11(1):1–20.

    CAS  PubMed  Google Scholar 

  28. Lauritsen J, Mortensen MS, Kier MG, Christensen IJ, Agerbaek M, Gupta R, et al. Renal impairment and late toxicity in germ-cell cancer survivors. Ann Oncol. 2015;26(1):173–8. doi:10.1093/annonc/mdu506.

    Article  CAS  PubMed  Google Scholar 

  29. Kollmannsberger C, Tandstad T, Bedard PL, Cohn-Cedermark G, Chung PW, Jewett MA, et al. Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance. J Clin Oncol. 2015;33(1):51–7. doi:10.1200/JCO.2014.56.2116.

    Article  PubMed  Google Scholar 

  30. Culine S, Kramar A, Theodore C, Geoffrois L, Chevreau C, Biron P, et al. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP. J Clin Oncol. 2008;26(3):421–7. doi:10.1200/JCO.2007.13.8461.

    Article  CAS  PubMed  Google Scholar 

  31. Motzer RJ, Nichols CJ, Margolin KA, Bacik J, Richardson PG, Vogelzang NJ, et al. Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors. J Clin Oncol. 2007;25(3):247–56. doi:10.1200/JCO.2005.05.4528.

    Article  CAS  PubMed  Google Scholar 

  32. Einhorn LH, Williams SD, Chamness A, Brames MJ, Perkins SM, Abonour R. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. N Engl J Med. 2007;357(4):340–8. doi:10.1056/NEJMoa067749.

    Article  CAS  PubMed  Google Scholar 

  33. Bhatia S, Abonour R, Porcu P, Seshadri R, Nichols CR, Cornetta K, et al. High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed testicular cancer. J Clin Oncol. 2000;18(19):3346–51.

    Article  CAS  PubMed  Google Scholar 

  34. Bokemeyer C, Harstrick A, Beyer J, Metzner B, Ruther U, Hartmann JT, et al. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group. Semin Oncol. 1998;25(2 Suppl 4):24–32. discussion 45–8

    CAS  PubMed  Google Scholar 

  35. Brown J, Friedlander M, Backes FJ, Harter P, O'Connor DM, de la Motte RT, et al. Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors. Int J Gynecol Cancer. 2014;24(9 Suppl 3):S48–54. doi:10.1097/IGC.0000000000000223.

    Article  PubMed  Google Scholar 

  36. Gershenson DM. Management of ovarian germ cell tumors. J Clin Oncol. 2007;25(20):2938–43. doi:10.1200/JCO.2007.10.8738.

    Article  CAS  PubMed  Google Scholar 

  37. Palenzuela G, Martin E, Meunier A, Beuzeboc P, Laurence V, Orbach D, et al. Comprehensive staging allows for excellent outcome in patients with localized malignant germ cell tumor of the ovary. Ann Surg. 2008;248(5):836–41. doi:10.1097/SLA.0b013e31818447cd.

    Article  PubMed  Google Scholar 

  38. Billmire D, Vinocur C, Rescorla F, Cushing B, London W, Schlatter M et al. Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. J Pediatr Surg. 2004;39(3):424–9; discussion 429.

    Google Scholar 

  39. Gershenson DM. Update on malignant ovarian germ cell tumors. Cancer. 1993;71(4 Suppl):1581–90.

    Article  CAS  PubMed  Google Scholar 

  40. Gershenson DM, Morris M, Cangir A, Kavanagh JJ, Stringer CA, Edwards CL, et al. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. J Clin Oncol. 1990;8(4):715–20.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mayo Clinic, 200, 1st St. SW, Rochester, MN, 55905, USA

    Manish Kohli MD & Brian A. Costello MD

  2. Division of Medical Oncology, Mayo Clinic, 200, 1st St. SW, Rochester, MN, 55905, USA

    Ben Y. Zhang MD

Authors
  1. Manish Kohli MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ben Y. Zhang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brian A. Costello MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manish Kohli MD .

Editor information

Editors and Affiliations

  1. Departamento de Anatomía Patológica, Universidad de Granada Facultad de Medicina, Granada, Spain

    Francisco F. Nogales

  2. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA

    Rafael E. Jimenez

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag GmbH Germany

About this chapter

Cite this chapter

Kohli, M., Zhang, B.Y., Costello, B.A. (2017). Management of Germ Cell Tumors. In: Nogales, F., Jimenez, R. (eds) Pathology and Biology of Human Germ Cell Tumors. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-53775-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-53775-6_5

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-53773-2

  • Online ISBN: 978-3-662-53775-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation